Gjest Breistein
Financieel Directeur/CFO bij LYTIX BIOPHARMA
Oorsprong van het eerstegraads netwerk van Gjest Breistein
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 12 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Gjest Breistein via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| PHOTOCURE ASA | Medical Specialties | Chief Executive Officer Chief Operating Officer | |
| University of Uppsala | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of Tromso | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Oslo | College/University | Graduate Degree Doctorate Degree | |
| PRECIGEN, INC. | Biotechnology | Corporate Officer/Principal Private Equity Investor | |
Storm Capital Management AS
 Storm Capital Management AS Investment ManagersFinance Storm Capital Management AS (SCM) is an asset management firm headquartered in Oslo, Norway. The firm was founded in 2006 by Morten Astrup. SCM focuses exclusively on the management of Storm Bond Fund, a Nordic Corporate Bond Fund (UCITS). | Investment Managers | Portfolio Manager-Equities | |
Svenska Handelsbanken AB (Broker)
 Svenska Handelsbanken AB (Broker) Investment Banks/BrokersFinance Svenska Handelsbanken AB (Broker) (Handelsbanken-Broker) is the broker/dealer division of Svenska Handelsbanken AB (STO: SHB-A; OTCMKTS: SVNLY) in Sweden. Headquartered in Stockholm, Handelsbanken-Broker was founded in 1871 and provides trading services to large corporates. The firm trades in equities, money market instruments, currencies, commodities and derivatives. | Investment Banks/Brokers | Analyst-Equity | |
| SERODUS ASA | Biotechnology | Director/Board Member | |
Redwood Bioscience, Inc.
 Redwood Bioscience, Inc. BiotechnologyHealth Technology Redwood Bioscience Inc. develops precision protein-chemical engineering technology to produce the next-generation of antibody-drug conjugates and other semi-synthetic biotherapeutics. It employs natural post translational modifications found in human cells to site specifically create one or more aldehyde tags on protein molecules, including monoclonal antibodies. The firm's platform is enabled with precision chemistries, payload positioning and defined stoichiometry of payload protein ratios. The company was founded by Carolyn R. Bertozzi, Mike Blank and David Rabuka in 2008 and is headquartered in Emeryville, CA. | Biotechnology | Corporate Officer/Principal | |
| University of Virginia | College/University | Doctorate Degree | |
Indi Molecular, Inc.
 Indi Molecular, Inc. BiotechnologyHealth Technology Indi Molecular, Inc. is a life sciences company that develops a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. It offers products used by physicians and patients to manage complex and serious diseases like cancer, diabetes, and Alzheimer's. The company was founded by Michael Phelps, Albert A. Luderer, Leroy E. Hood, and Jim Heath in 2013 and is headquartered in Culver City, CA. | Biotechnology | Corporate Officer/Principal | |
Pre Diagnostics AS
 Pre Diagnostics AS Medical/Nursing ServicesHealth Services Pre Diagnostics AS develops in-vitro diagnostic (IVD) products for early detection of diseases. It focuses on the development of IVD biomarker products that use well-established technologies and procedures. The company was founded by Ole Peter Nordby, Hakon Saeteroy, and Erik Christensen on October 25, 2013 and is headquartered in Oslo, Norway. | Medical/Nursing Services | Founder | |
Idia AS
 Idia AS Food: Major DiversifiedConsumer Non-Durables Idia AS provides nutritional ingredient. It offers ingredient to the food and beverage industries. The company was founded by Ole Peter Nordby and is headquartered in Oslo, Norway. | Food: Major Diversified | Founder | |
Xalud Therapeutics, Inc.
 Xalud Therapeutics, Inc. BiotechnologyHealth Technology Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
| VERRICA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Operating Officer | |
PBM Capital Group LLC
 PBM Capital Group LLC Investment ManagersFinance PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia. | Investment Managers | Private Equity Investor | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BI Norwegian Business School | College/University | Masters Business Admin | |
| University of Virginia Darden School of Business | College/University | Masters Business Admin | |
Ilya Pharma AB
 Ilya Pharma AB BiotechnologyHealth Technology Ilya Pharma AB develops biological drugs for treating wounds in skin and mucosa. The company was incorporated in May 13, 2016 by Mia Johanna Phillipson, Stefan Roos and Evelina Wanda Matilda Vågesjö and is headquartered in Uppsala, Sweden. | Biotechnology | Chief Executive Officer | |
| BIOVICA INTERNATIONAL AB | Biotechnology | Director/Board Member | |
| FARON PHARMACEUTICALS OY | Pharmaceuticals: Major | Director/Board Member | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MERUS N.V. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| SENSEI BIOTHERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Heriot-Watt University | College/University | Masters Business Admin | |
GE Healthcare AS
 GE Healthcare AS Medical SpecialtiesHealth Technology GE Healthcare AS markets contrast agent for x-ray, ultrasound, Magnetic Resonance Imaging, and radiopharmaceuticals for clinicians to predict, diagnose, inform, and treat diseases. The company was founded on September 07, 1981 and it is headquartered in Oslo, Norway. | Medical Specialties | Corporate Officer/Principal | |
| Rollins College (Florida) | College/University | Undergraduate Degree | |
Helmholtz Zentrum München
 Helmholtz Zentrum München Miscellaneous Commercial ServicesCommercial Services Helmholtz Zentrum München is a research center located in Munich, Germany. The center's mission is to discover personalized medical solutions for the prevention and therapy of environmentally triggered diseases and promote a healthier society in a rapidly changing world. Helmholtz Zentrum München investigates the interaction of genetics, environmental factors, and lifestyle to achieve this goal. The center is a member of the Helmholtz Association, the largest scientific organization with more than 40,000 employees at 19 research centers. Helmholtz Zentrum München has approximately 2,500 staff members and is headquartered in Neuherberg in the north of Munich. | Miscellaneous Commercial Services | Chief Executive Officer | |
| ARCTICZYMES TECHNOLOGIES ASA | Medical Specialties | Chairman | |
| University of London | College/University | Doctorate Degree | |
ImevaX GmbH
 ImevaX GmbH BiotechnologyHealth Technology ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany. | Biotechnology | Chief Executive Officer | |
| PATRYS LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Pharmaceuticals: Major | Director/Board Member | |
| OHM Technologies | Corporate Officer/Principal | ||
Centrose LLC
 Centrose LLC Pharmaceuticals: MajorHealth Technology Centrose LLC discovers and develops therapeutics. It focuses on the chemistry and biology unique to the creation of EDC technology. The company was founded by James R. Prudent in 2007 and is headquartered in Middleton, WI. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Chairman | |
FosenNamsos Sjø AS
 FosenNamsos Sjø AS Marine ShippingTransportation FosenNamsos Sjø AS provides collective transportation services. It offers ferries and express boats. The company was founded on September 11, 2008 and is headquartered in Trondheim, Norway. | Marine Shipping | Director/Board Member | |
| Hifo Invest AS | Chairman | ||
TTS Bil og Dekksenter AS
 TTS Bil og Dekksenter AS Other Consumer ServicesConsumer Services TTS Bil og Dekksenter AS is a local workshop service provider in Sør-Helgeland that offers gas propane for various purposes such as heating boats and gas-powered stoves. The private company is based in Sør-Helgeland, Norway. The Norwegian company has a modern workshop and is committed to providing efficient and environmentally friendly energy solutions. | Other Consumer Services | Chairman | |
| Brønnøysund Havneterminal AS | Chief Executive Officer | ||
| Sør-Helgeland Vaktselskap AS | Chairman | ||
Saturn Invest AS
 Saturn Invest AS Financial ConglomeratesFinance Saturn Invest AS owns, acquires, and trades shares and units. Thee company was founded on December 14, 2005 and is headquartered in Bronnoysund, Norway. | Financial Conglomerates | Chief Executive Officer | |
| NORTH ENERGY ASA | Financial Conglomerates | Director/Board Member | |
| Torghatten Trafikkselskap AS | Chief Executive Officer | ||
| North SEA Safety KS | Director/Board Member | ||
Torghatten ASA
 Torghatten ASA Marine ShippingTransportation Torghatten ASA engages in the provision of bus and air transportation services. It operates through the following segments: Marine Company, Bus Company, Airlines, Other Maritime, and Other. The Marine Company segment includes operation of ferry, speedboat, and associated café. The Bus Company segment manages bus and freight car, as well as associated workshop activities. The Airlines segment focuses on the airline business. The Other Maritime segment comprise of shipping and maritime construction. The Other segment refers to the external workshop operations, travel agency operations, property management, action, and security activities. The company was founded on January 3, 1878 and is headquartered in Bronnoysund, Norway. | Marine Shipping | Chief Executive Officer |
Statistieken
Internationaal
| Noorwegen | 24 |
| Verenigde Staten | 16 |
| Zweden | 5 |
| Verenigd Koninkrijk | 3 |
| Duitsland | 3 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 11 |
| Finance | 6 |
| Transportation | 4 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 29 |
| Corporate Officer/Principal | 18 |
| Chairman | 15 |
| Chief Executive Officer | 14 |
| Chief Tech/Sci/R&D Officer | 10 |
Sterkste connecties
- Beurs
- Insiders
- Gjest Breistein
- Bedrijfsconnecties
